Raphael Ognar

Company: NKILT Therapeutics

Job title: President, Chief Executive Officer , Co-Founder & Chairman of the Board

Seminars:

Building Novel Cell Designs to Deliver “Serial Killer” Engineered NK Cells with Enhanced Potency & Persistence 1:30 pm

Incorporating advanced genetic modifications that enhance T-cell and NK cell functionality for maximal anti-tumor activity Increasing survival and efficacy against solid tumorsRead more

day: Day Two - Track A PM

Industry Leaders’ Fireside Chat: Achieving Allogeneic Product Success by Aligning Innovation with Investor Expectations 8:10 am

An interactive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space.  Ask your questions live to understand the expert’s thoughts on key topics including: Evaluating key success factors for allogeneic therapies and how they differ from autologous approaches Discussing the role of clinical trial outcomes…Read more

day: Conference Day One